Dr. Jennifer Marquez is a visionary healthcare executive, Board Certified Oncology Pharmacist, pharmacogenomics pioneer, educator, and entrepreneur whose career has been defined by an unwavering commitment to improving patient outcomes through innovation and personalized medicine. Over the course of more than twenty-four years in clinical pharmacy and healthcare leadership, she has become a recognized voice in oncology, precision medicine, pharmacogenomics, and patient advocacy. Her ability to bridge scientific discovery with practical clinical application has positioned her as a respected leader who consistently transforms complex genomic science into meaningful strategies that improve healthcare delivery, empower providers, and ultimately enhance the lives of patients around the world.
Throughout her career, Dr. Marquez has demonstrated an exceptional ability to combine clinical excellence with strategic vision. Beginning her professional journey in ambulatory care, she quickly established herself as a pharmacist who looked beyond medications alone, recognizing the importance of education, accessibility, and interdisciplinary collaboration in achieving better patient outcomes. Her work managing grant-funded medication assistance clinics, counseling patients with chronic illnesses, and collaborating with physicians laid a strong foundation for a career centered on compassionate, patient-focused care. Those early experiences reinforced her belief that healthcare innovation must always remain accessible and equitable for every patient regardless of circumstance.
Today, Dr. Marquez serves as Chief Pharmacogenomics Officer for Antares Genomics, where she helps lead the organization’s precision medicine initiatives across Africa and beyond. In this executive leadership role, she contributes to the development of pharmacogenomic implementation programs, educational resources, clinical decision support technologies, and strategic business initiatives designed to integrate genetic testing into everyday medical practice. Her work extends beyond organizational leadership, as she actively collaborates with healthcare professionals, researchers, technology developers, and policymakers to expand access to personalized medicine and improve healthcare outcomes across diverse populations. Her international work, particularly throughout South Africa, reflects her commitment to creating sustainable healthcare solutions with global impact.
Alongside her executive leadership responsibilities, Dr. Marquez has built an impressive academic career as a Guest Lecturer and Course Coordinator for the Master of Science in Pharmacogenomics program at the University of Zambia. In this capacity, she develops graduate-level curriculum, mentors future healthcare professionals, and teaches the clinical application of pharmacogenomics within modern healthcare systems. Her educational philosophy centers on translating emerging scientific discoveries into practical knowledge that clinicians can immediately apply in patient care. Through teaching, mentorship, and international collaboration, she is helping shape the next generation of precision medicine leaders while strengthening global educational partnerships in genomic healthcare.
Dr. Marquez has simultaneously maintained an extensive clinical practice as a Hematology and Oncology Clinical Pharmacy Specialist at Piedmont Columbus John B. Amos Cancer Center, where she has served oncology patients for nearly two decades. Her clinical responsibilities include chemotherapy regimen development, pharmacogenomic testing implementation, medication therapy optimization, clinical trial support, electronic medical record integration, and collaborative treatment planning alongside multidisciplinary oncology teams. Her expertise has contributed to improved medication safety, enhanced treatment precision, and more personalized therapeutic decision-making for cancer patients. Her leadership in implementing pharmacogenomic testing initiatives has further positioned her organization at the forefront of precision oncology.
Entrepreneurship has also become a defining component of Dr. Marquez’s professional journey. As Founder and Chief Executive Officer of PharmDNA, LLC, she created a platform dedicated to educating both patients and healthcare providers about drug-gene interactions and personalized medicine. Through consulting, digital education, speaking engagements, webinars, and social media outreach, she has expanded awareness of pharmacogenomics while making complex scientific concepts understandable to both clinicians and the general public. Her entrepreneurial vision reflects her ability to identify emerging healthcare needs and develop innovative educational solutions that support both clinical excellence and patient empowerment.
Beyond her executive, clinical, and entrepreneurial accomplishments, Dr. Marquez has established herself as an influential advocate for equitable healthcare and genomic diversity. She actively champions universal DPD/DPYD testing to reduce chemotherapy toxicity while advocating for broader implementation of pharmacogenomic testing across healthcare systems. Her contributions to the 108,000 African Genomes Project demonstrate her dedication to ensuring that genomic research represents diverse populations and addresses longstanding disparities in precision medicine. Through research, publications, speaking engagements, and professional collaboration, she continues to influence the future direction of pharmacogenomics while promoting more inclusive healthcare innovation.
Dr. Marquez has authored numerous publications addressing pharmacogenomics, precision medicine, and the evolving role of pharmacists in personalized healthcare. She regularly contributes educational articles and has been featured in professional publications including Medical Science Monitor, RX Influencer Magazine, and Women in Pharma Careers. She is also an accomplished public speaker, delivering presentations, webinars, podcasts, and international educational sessions on pharmacogenomics implementation, oncology, drug metabolism, precision medicine, and career development. Her ability to communicate advanced scientific concepts with clarity has made her a sought-after educator and thought leader within the healthcare community.
As she enters the next chapter of her distinguished career, Dr. Marquez is actively pursuing opportunities to serve on corporate and advisory boards where she can contribute her unique combination of clinical expertise, executive leadership, entrepreneurial experience, and strategic vision. Having successfully built programs, educated healthcare professionals, developed business strategies, and advanced precision medicine initiatives, she brings a valuable systems-level perspective to governance. She understands not only the scientific and operational aspects of healthcare organizations, but also the broader implications corporate decisions have on patient outcomes, healthcare accessibility, and organizational growth. Her board contributions would be strengthened by her ability to balance innovation with practical execution while maintaining an unwavering commitment to ethical, patient-centered leadership.
Dr. Jennifer Marquez’s career reflects far more than professional achievement—it represents a lifelong mission to transform healthcare through education, innovation, collaboration, and compassion. Whether leading pharmacogenomic initiatives, mentoring future healthcare professionals, advancing international partnerships, advocating for underserved populations, or shaping organizational strategy, she consistently demonstrates a leadership style grounded in service and purpose. Her work continues to redefine how personalized medicine is implemented across healthcare systems, leaving a lasting impact on patients, providers, researchers, and organizations worldwide.
Character:
Dr. Marquez leads with integrity, empathy, and an unwavering commitment to improving the lives of patients through personalized healthcare. Her servant-leadership approach, compassion, and dedication to advancing equitable access to genomic medicine have earned the respect of colleagues, students, and healthcare professionals across multiple disciplines.
Knowledge:
With more than twenty-four years of experience spanning oncology, pharmacogenomics, clinical pharmacy, education, and entrepreneurship, she possesses exceptional depth of expertise in precision medicine. Her published research, clinical leadership, academic instruction, and global collaborations demonstrate her ability to translate cutting-edge science into meaningful healthcare solutions.
Strategic:
Dr. Marquez consistently approaches challenges with a systems-thinking mindset that integrates clinical innovation, organizational strategy, technology, and patient outcomes. She has successfully built educational programs, guided pharmacogenomic implementation initiatives, contributed to business strategy, and developed scalable solutions that position organizations for long-term success.
Communication:
An accomplished educator, international speaker, and published author, she excels at making highly technical scientific concepts accessible to diverse audiences. Her collaborative communication style enables her to build trusted relationships with executive leaders, clinicians, researchers, educators, patients, and cross-functional teams while inspiring innovation and shared purpose.
https://www.antaresgenomics.com/
